Back

Associations of fasting state glycemic biomarkers with mortality and morbidity in heart failure: Retrospective cohort study

27 August 2023 (12:15 - 12:50)
Organised by: Logo
Congress Presentation Part of: The growing importance of phenotyping in heart failure Epidemiology, Prognosis, Outcome ESC Professional Premium Access ESC Congress 2023 European Society of Cardiology

About the speaker

Photo
Doctor Keiichiro Iwasaki

Okayama University Hospital, Okayama (Japan)

5 More presentations in this session

Presentation thumbnail
Transthyretin amyloid cardiomyopathy among patients with hypertrophic cardiomyopathy: clinical, cardiac imaging, and electrocardiographic findings from the TTRACK study
Professor P. Garcia-Pavia (Majadahonda, ES)
Abstract Slides Video
Presentation thumbnail
Prognostic value of pulmonary hypertension in patients with advanced heart failure evaluated fort heart replacement therapy in the light of new definition of pulmonary hypertension.
Doctor A. Minervini (Bologna, IT)
Abstract Slides Video
Presentation thumbnail
Usefulness of a scoring evaluation for practical introduction of the guideline-directed medical therapy (GDMT) in heart failure patients
Doctor R. Matsukawa (Iizuka, JP)
Abstract Slides Video
Presentation thumbnail
Level of education and mortality in the vulnerable period following an acute heart failure hospitalization
Doctor G. Pereira Da Cunha (Curitiba, BR)
Abstract Slides Video
Presentation thumbnail
Red cell distribution width (RDW) to serum albumin ratio (RAR) in chronic heart failure
Doctor A. Toste (Porto, PT)
Abstract Slides Video

Access the full session

Session thumbnail
The growing importance of phenotyping in heart failure

The Event

Event poster

ESC Congress 2023

27 August 2023 12:15 CET
You may be interested in
thumbnail
Congress Presentation
The underestimated risk of prediabetes on cardiovascular and renal outcomes in patients with heart failure
thumbnail
Congress Presentation
Long-term prognostic impact of fasting plasma glucose and myocardial flow reserve beyond other risk factors and heart disease phenotypes
thumbnail
Congress Presentation
The underestimated risk of prediabetes on cardiovascular outcomes in heart failure with reduced left ventricular function

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources